Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs

Alessandro Dalpiaz, Barbara Pavan, Silvia Vertuani, Federica Vitali, Martina Scaglianti, Fabrizio Bortolotti, Carla Biondi, Angelo Scatturin, Sergio Tanganelli, Luca Ferraro, Giuliano Marzola, Puttur D Prasad, Stefano Manfredini

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Ascorbic acid (AA) or 6-Br-ascorbate (BrAA) conjugation has been investigated as a tool to improve brain drug delivery by the Vitamin C transporter SVCT2. To this aim, the effects of AA- or BrAA-conjugation on drug affinity and uptake have been assessed in vitro, by using human retinal pigment epithelium (HRPE) cells, and compared in vivo on mice. Nipecotic, kynurenic and diclofenamic acids were chosen as model drugs. Kinetic and inhibition experiments referred to [14C]AA uptake into HRPE cells showed that nipecotic and kynurenic acids became able to interact with SVCT2, as competitive inhibitors, only when conjugated to AA or BrAA. Surprisingly, diclofenamic acid itself appeared able to interact with SVCT2, with an affinity that was significantly increased or decreased by AA or BrAA conjugation, respectively. HPLC analysis, performed on HRPE cells, confirmed the SVCT2 mediated transport for the BrAA-conjugate of nipecotic acid, whereas kynurenic acids conjugates although interacting with the transporter did not enter the cells. In accordance, only the nipecotic acid conjugates showed anticonvulsant activity after systemic injection in mice.

Original languageEnglish (US)
Pages (from-to)259-269
Number of pages11
JournalEuropean Journal of Pharmaceutical Sciences
Volume24
Issue number4
DOIs
StatePublished - Jan 1 2005

Fingerprint

Therapeutic Uses
Ascorbic Acid
Retinal Pigment Epithelium
Pharmaceutical Preparations
Kynurenic Acid
Nipecotic Acids
Anticonvulsants
High Pressure Liquid Chromatography
Injections
Acids
Brain

Keywords

  • Brain delivery
  • Drug targeting
  • HRPE cells
  • SVCT2 transporter
  • Vitamin C

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs. / Dalpiaz, Alessandro; Pavan, Barbara; Vertuani, Silvia; Vitali, Federica; Scaglianti, Martina; Bortolotti, Fabrizio; Biondi, Carla; Scatturin, Angelo; Tanganelli, Sergio; Ferraro, Luca; Marzola, Giuliano; Prasad, Puttur D; Manfredini, Stefano.

In: European Journal of Pharmaceutical Sciences, Vol. 24, No. 4, 01.01.2005, p. 259-269.

Research output: Contribution to journalArticle

Dalpiaz, A, Pavan, B, Vertuani, S, Vitali, F, Scaglianti, M, Bortolotti, F, Biondi, C, Scatturin, A, Tanganelli, S, Ferraro, L, Marzola, G, Prasad, PD & Manfredini, S 2005, 'Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs', European Journal of Pharmaceutical Sciences, vol. 24, no. 4, pp. 259-269. https://doi.org/10.1016/j.ejps.2004.10.014
Dalpiaz, Alessandro ; Pavan, Barbara ; Vertuani, Silvia ; Vitali, Federica ; Scaglianti, Martina ; Bortolotti, Fabrizio ; Biondi, Carla ; Scatturin, Angelo ; Tanganelli, Sergio ; Ferraro, Luca ; Marzola, Giuliano ; Prasad, Puttur D ; Manfredini, Stefano. / Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs. In: European Journal of Pharmaceutical Sciences. 2005 ; Vol. 24, No. 4. pp. 259-269.
@article{1a6c73e33c694155a5731074123e0ebf,
title = "Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs",
abstract = "Ascorbic acid (AA) or 6-Br-ascorbate (BrAA) conjugation has been investigated as a tool to improve brain drug delivery by the Vitamin C transporter SVCT2. To this aim, the effects of AA- or BrAA-conjugation on drug affinity and uptake have been assessed in vitro, by using human retinal pigment epithelium (HRPE) cells, and compared in vivo on mice. Nipecotic, kynurenic and diclofenamic acids were chosen as model drugs. Kinetic and inhibition experiments referred to [14C]AA uptake into HRPE cells showed that nipecotic and kynurenic acids became able to interact with SVCT2, as competitive inhibitors, only when conjugated to AA or BrAA. Surprisingly, diclofenamic acid itself appeared able to interact with SVCT2, with an affinity that was significantly increased or decreased by AA or BrAA conjugation, respectively. HPLC analysis, performed on HRPE cells, confirmed the SVCT2 mediated transport for the BrAA-conjugate of nipecotic acid, whereas kynurenic acids conjugates although interacting with the transporter did not enter the cells. In accordance, only the nipecotic acid conjugates showed anticonvulsant activity after systemic injection in mice.",
keywords = "Brain delivery, Drug targeting, HRPE cells, SVCT2 transporter, Vitamin C",
author = "Alessandro Dalpiaz and Barbara Pavan and Silvia Vertuani and Federica Vitali and Martina Scaglianti and Fabrizio Bortolotti and Carla Biondi and Angelo Scatturin and Sergio Tanganelli and Luca Ferraro and Giuliano Marzola and Prasad, {Puttur D} and Stefano Manfredini",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.ejps.2004.10.014",
language = "English (US)",
volume = "24",
pages = "259--269",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs

AU - Dalpiaz, Alessandro

AU - Pavan, Barbara

AU - Vertuani, Silvia

AU - Vitali, Federica

AU - Scaglianti, Martina

AU - Bortolotti, Fabrizio

AU - Biondi, Carla

AU - Scatturin, Angelo

AU - Tanganelli, Sergio

AU - Ferraro, Luca

AU - Marzola, Giuliano

AU - Prasad, Puttur D

AU - Manfredini, Stefano

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Ascorbic acid (AA) or 6-Br-ascorbate (BrAA) conjugation has been investigated as a tool to improve brain drug delivery by the Vitamin C transporter SVCT2. To this aim, the effects of AA- or BrAA-conjugation on drug affinity and uptake have been assessed in vitro, by using human retinal pigment epithelium (HRPE) cells, and compared in vivo on mice. Nipecotic, kynurenic and diclofenamic acids were chosen as model drugs. Kinetic and inhibition experiments referred to [14C]AA uptake into HRPE cells showed that nipecotic and kynurenic acids became able to interact with SVCT2, as competitive inhibitors, only when conjugated to AA or BrAA. Surprisingly, diclofenamic acid itself appeared able to interact with SVCT2, with an affinity that was significantly increased or decreased by AA or BrAA conjugation, respectively. HPLC analysis, performed on HRPE cells, confirmed the SVCT2 mediated transport for the BrAA-conjugate of nipecotic acid, whereas kynurenic acids conjugates although interacting with the transporter did not enter the cells. In accordance, only the nipecotic acid conjugates showed anticonvulsant activity after systemic injection in mice.

AB - Ascorbic acid (AA) or 6-Br-ascorbate (BrAA) conjugation has been investigated as a tool to improve brain drug delivery by the Vitamin C transporter SVCT2. To this aim, the effects of AA- or BrAA-conjugation on drug affinity and uptake have been assessed in vitro, by using human retinal pigment epithelium (HRPE) cells, and compared in vivo on mice. Nipecotic, kynurenic and diclofenamic acids were chosen as model drugs. Kinetic and inhibition experiments referred to [14C]AA uptake into HRPE cells showed that nipecotic and kynurenic acids became able to interact with SVCT2, as competitive inhibitors, only when conjugated to AA or BrAA. Surprisingly, diclofenamic acid itself appeared able to interact with SVCT2, with an affinity that was significantly increased or decreased by AA or BrAA conjugation, respectively. HPLC analysis, performed on HRPE cells, confirmed the SVCT2 mediated transport for the BrAA-conjugate of nipecotic acid, whereas kynurenic acids conjugates although interacting with the transporter did not enter the cells. In accordance, only the nipecotic acid conjugates showed anticonvulsant activity after systemic injection in mice.

KW - Brain delivery

KW - Drug targeting

KW - HRPE cells

KW - SVCT2 transporter

KW - Vitamin C

UR - http://www.scopus.com/inward/record.url?scp=20044368980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044368980&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2004.10.014

DO - 10.1016/j.ejps.2004.10.014

M3 - Article

VL - 24

SP - 259

EP - 269

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 4

ER -